Almac Pharma Services has completed Phase 1 of the expansion to its headquarters in Craigavon, Northern Ireland. Supported by Invest Northern Ireland, a total of US$15m (£9m) will be spent in two phases.
A three-storey extension to the existing commercial manufacturing facility has now been completed, which has expanded Pharma Services" laboratory and office areas by 2,500m2. The new state-of-the-art laboratories enhance the existing analytical and microbiological services.
Phase 2 is ongoing and the expansion and update of the administration areas will be completed later this summer.
The investment is part of the continued growth of the Almac Group, including the recent completion of a specialist storage facility in Craigavon and the ongoing development of its 22,000m2 US headquarters in Pennsylvania.
Graeme McBurney, president and md of Almac Pharma Services, said: "Increased client demand for our integrated services, from product development to commercial supply, has resulted in this investment and expansion. Analytical and project management expertise and support in these service areas are a key part of providing a complete solution to our client partners."
"The provision of expert and consultative analytical services has also been key to our continued growth, and this significant investment allows for ongoing expansion, both in terms of space and the additional team members we will be recruiting," he added.
